American Journal of Respiratory Cell and Molecular Biology Citation Rate 2026
1044-1549
eISSN 1535-4989
American Thoracic Society
US
Q1 Quartile Top Tier Fast Review
About American Journal of Respiratory Cell and Molecular Biology
American Journal of Respiratory Cell and Molecular Biology (AJRCMB) is a peer-reviewed academic journal covering Asthma and respiratory diseases and Immune Response and Inflammation, published by American Thoracic Society in US, catalogued under ISSN 1044-1549 (e-ISSN 1535-4989). As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.50 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model. OpenAlex records 7,523 works and 392,457 citations, with an h-index of 213.
Authors typically receive a first decision in around 39 days.
American Journal of Respiratory Cell and Molecular Biology Citation Rate 2026 — In Context
American Journal of Respiratory Cell and Molecular Biology has a 2024 2-Year Citation Rate (OpenAlex) of 64.50, placing it in the Q1 quartile within the Asthma and respiratory diseases research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
American Journal of Respiratory Cell and Molecular Biology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view. Average submission-to-decision turnaround is approximately 39 days — fast by sector standards.
Researchers looking to publish in American Journal of Respiratory Cell and Molecular Biology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare American Journal of Respiratory Cell and Molecular Biology against similar journals in the field, use our journal comparison tool.
Submission Tips for American Journal of Respiratory Cell …
- The average time from submission to first decision is 39 days, which is moderate for the field.
- This journal covers Asthma and respiratory diseases, Immune Response and Inflammation, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How American Journal of … Compares
Compared against 52 journals in the same research areas.
| ISSN (Print) | 1044-1549 |
|---|---|
| ISSN (Online) | 1535-4989 |
| Publisher | American Thoracic Society |
| Country | United States |
| APC / Cost | Inquire with Publisher |
| Review Speed | ~39 days to first decision |
| h-index | 213 |
| Total Works | 7,488 |
| Total Citations | 393,613 |
| 2-yr Mean Citedness | 2.97 (OpenAlex) |
In-depth profile & metrics
American Journal of Respiratory Cell and Molecular Biology is published by American Thoracic Society and based in United States.
In our subject taxonomy, American Journal of Respiratory Cell and Molecular Biology is classified under Asthma and respiratory diseases, Immune Response and Inflammation, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Neonatal Respiratory Health Research.
American Journal of Respiratory Cell and Molecular Biology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
For prospective authors, American Journal of Respiratory Cell and Molecular Biology returns a first decision in about 39 days (moderate for its field).
OpenAlex records 7,488 works that have together drawn 393,613 citations, giving the journal an h-index of 213; its citation rate has held broadly steady over the last 1 years, from 61.275 (2023) to 64.500 (2024); OpenAlex puts its two-year mean citedness at 2.97.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about American Journal of Respiratory Cell …
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
The impact factor has remained stable over the last 1 years (from 61.275 to 64.500), reflecting consistent citation performance.
Citation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.500 | 2-Year Mean Citedness (OpenAlex) |
| 2023 | 61.275 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 204 | 469 |
| 2024 | 219 | 1,261 |
| 2023 | 173 | 1,423 |
| 2022 | 210 | 2,759 |
| 2021 | 204 | 3,372 |
| 2020 | 224 | 6,129 |
| 2019 | 213 | 6,107 |
| 2018 | 248 | 6,891 |
| 2017 | 253 | 10,681 |
| 2016 | 145 | 6,410 |
| 2015 | 176 | 8,133 |
| 2014 | 222 | 10,748 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where American Journal of Respiratory Cell … most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Journal Metrics
Compare Journals
Compare American Journal of Respirato… against similar publications in its field:
Related Journals in Your Field
-
Immunity Cell Press IF 19.59
-
Drugs Adis, Springer Healthcare IF 9.72
-
Immunological Reviews Wiley IF 8.21
-
International Immunopharmacology Elsevier BV IF 4.82
-
Respiratory Research BioMed Central IF 4.80
Explore More Journals
Metadata
Last updated: Mar 20, 2026
Updated by: system
Get weekly updates for Asthma and respiratory diseases journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.